Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

October 25, 2025

Study Completion Date

October 25, 2025

Conditions
Severe HypoglycemiaType1diabetes
Interventions
DIAGNOSTIC_TEST

Insulin-induced hypoglycemia test

For these tests, multiple blood samples will be collected during insulin-induced hypoglycemia (stage 1 hypoglycemia is defined as a blood glucose level below 70 mg/dL, while stage 2 corresponds to values below 54 mg/dL). The tests will be conducted on patients who have fasted for at least 12 hours and will be supervised by a medical staff member trained to manage severe hypoglycemia.

DIAGNOSTIC_TEST

Glucagon profile

The subject must fast before the consultation and follow a specific diet the day before; after an initial blood draw (P1), the patient will have breakfast and take any required insulin, followed by two additional blood draws 1.5 hours after breakfast (P2) and 1.5 hours after P2 (P3)

OTHER

Biological sample once

The exome of each patient will then be analyzed from the blood sample taken beforehand.

OTHER

Observation-questionnaire

only the answer to a questionnaire

Trial Locations (1)

1200

RECRUITING

Clinique Universitaires Saint Luc, Brussels

All Listed Sponsors
collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER